LYTIR

Company · NSPR

InspireMD Inc.

Name as listed on its exchange; filed with the SEC as InspireMD, Inc.

Nasdaq's symbol directory lists NSPR on Nasdaq as “InspireMD Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 5 occasions ($455K); 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Paul Stuka bought on 1 day latest Nov 13, 2026 bought $200K
  2. Gary S. Roubin bought on 1 day latest Nov 13, 2026 bought $100K
  3. Michael A. Lawless, Chief Financial Officer bought on 1 day latest Nov 13, 2026 bought $75K
  4. Michael Berman bought on 1 day latest Nov 13, 2026 bought $50K
  5. Marvin Slosman, CEO and President bought on 1 day latest Nov 13, 2026 bought $30K
Every trade (5)
  1. BUYPaul Stuka bought Nov 13, 2026 307,693 shares filing $200K
  2. BUYGary S. Roubin bought Nov 13, 2026 153,846 shares filing $100K
  3. BUYMichael A. Lawless, Chief Financial Officer bought Nov 13, 2026 115,385 shares filing $75K
  4. BUYMichael Berman bought Nov 13, 2026 76,923 shares filing $50K
  5. BUYMarvin Slosman, CEO and President bought Nov 13, 2026 46,154 shares filing $30K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Entry into a material definitive agreement; Other events filing Nov 16, 2026
  2. Results of operations and financial condition; Other events filing Nov 12, 2026
  3. Regulation FD disclosure; Other events filing Nov 12, 2026
  4. Entry into a material definitive agreement; Unregistered sales of equity securities; Regulation FD disclosure filing Sep 21, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.